Abstract
Sharing the burden of low-volume metastatic cancer between ICB and local treatments.
MeSH terms
-
Humans
-
Immune Checkpoint Inhibitors* / therapeutic use
-
Neoplasm Metastasis
-
Neoplasms / drug therapy
-
Neoplasms / immunology
-
Neoplasms / therapy
-
Tumor Burden
Substances
-
Immune Checkpoint Inhibitors